new glp-1 drugs in development The Multi-Sector Impacts of GLP-1RA GLP-1 2.0: Where the Next

It is listed in the Russian Pharmacopoeia

* Sweating * Headache * Dizziness **Very Rare Side Effects (may affect up to 1 in 10,000 people):** * Acne **Not Known (frequency cannot be estimated from the available data):** * Nerve damage (neuropathy) with prolonged use

A study has also reported that RGSH can effectively eliminate oxygen free radicals and treat the AKI rats with ischemia reperfusion (29)

Under physiological conditions, Cys-SSH and GSSH are major products, and even though Cys-SS n H and GSS n H are produced, they may be immediately reduced by cysteine and GSH

Thus, the compensation provided by these connected pathways in alleviating oxidative stress in cancer cells is supportive of a therapeutic strategy based on dual pathway inhibition